These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30411033)

  • 1. Resveratrol Sustains Insulin-Degrading Enzyme Activity toward Aβ42.
    Krasinski CA; Ivancic VA; Zheng Q; Spratt DE; Lazo ND
    ACS Omega; 2018 Oct; 3(10):13275-13282. PubMed ID: 30411033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme.
    Zheng Q; Kebede MT; Lee B; Krasinski CA; Islam S; Wurfl LA; Kemeh MM; Ivancic VA; Jakobsche CE; Spratt DE; Lazo ND
    Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study.
    Bora RP; Prabhakar R
    Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
    Hubin E; Cioffi F; Rozenski J; van Nuland NA; Broersen K
    Biochim Biophys Acta; 2016 Jun; 1860(6):1281-90. PubMed ID: 26968463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzyme.
    da Cruz CH; Seabra G
    J Chem Inf Model; 2014 May; 54(5):1380-90. PubMed ID: 24697863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
    Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.
    Cam M; Durieu E; Bodin M; Manousopoulou A; Koslowski S; Vasylieva N; Barnych B; Hammock BD; Bohl B; Koch P; Omori C; Yamamoto K; Hata S; Suzuki T; Karg F; Gizzi P; Erakovic Haber V; Bencetic Mihaljevic V; Tavcar B; Portelius E; Pannee J; Blennow K; Zetterberg H; Garbis SD; Auvray P; Gerber H; Fraering J; Fraering PC; Meijer L
    J Alzheimers Dis; 2018; 62(4):1663-1681. PubMed ID: 29504531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
    Zhang H; Liu D; Huang H; Zhao Y; Zhou H
    Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
    Pivovarova O; Höhn A; Grune T; Pfeiffer AF; Rudovich N
    Ann Med; 2016 Dec; 48(8):614-624. PubMed ID: 27320287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
    Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
    Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wines and grape juices as modulators of platelet aggregation in healthy human subjects.
    Pace-Asciak CR; Rounova O; Hahn SE; Diamandis EP; Goldberg DM
    Clin Chim Acta; 1996 Mar; 246(1-2):163-82. PubMed ID: 8814965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque.
    Kulstad JJ; McMillan PJ; Leverenz JB; Cook DG; Green PS; Peskind ER; Wilkinson CW; Farris W; Mehta PD; Craft S
    J Neuropathol Exp Neurol; 2005 Feb; 64(2):139-46. PubMed ID: 15751228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Biomol Struct Dyn; 2019 Aug; 37(12):3183-3197. PubMed ID: 30582723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease.
    Kirabali T; Rigotti S; Siccoli A; Liebsch F; Shobo A; Hock C; Nitsch RM; Multhaup G; Kulic L
    Acta Neuropathol Commun; 2019 Dec; 7(1):194. PubMed ID: 31796114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
    de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
    Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.